Evusheld este una dintre singurele două terapii cu anticorpi autorizate eficiente împotriva Omicron și a tuturor celorlalte variante de Covid-19 analizate în aceste studii. Evusheld este singurul anticorp monoclonal autorizat în SUA pentru profilaxia pre-expunere a COVID-19.
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2021/12/evusheld-547887987654.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2021/11/radiografie_plamani_medic_bpoc-748x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2021/04/50742483287_75c65ef65d_b-630x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2021/03/1017188_cc23721e8139be1a1131d329e20378fa-630x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2021/03/astra-zeneca-747x420.png)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2021/01/vaccin_astrazeneca_91461400-747x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2021/02/vaccin_coronavirus_645766_80843900.JPG)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2015/12/astrazeneca_87403700-754x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/12/pfizer_biontech_covid_19_vaccine_2020_c_cropped_09724400-326x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/12/bucharrest_business_park_80984100-633x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/09/1140_flut_shot_75596200-731x420.jpg)
:format(webp):quality(92)/https://www.economica.net/wp-content/uploads/2020/07/vaccin_7658490685940_08042100.jpg)
